Dr Camille Lombard-Banek
NCR Postdoctoral Fellow, NIST/IBBR, John Schiel
Development of a Sensitive SWATH™ MS Workflow To Advance the Characterization of CAR T-Cell Therapies
CAR T-cell therapies are emerging anti-cancer treatments, whereby the patient’s immune cells are engineered to express chimeric antigen receptors (CARs) on their surface. Wider adoption of this therapeutic modality would benefit from innovative technologies that can improve the characterization of raw material quality attributes (MQA) and final product quality attributes (PQA).